#Generic Pharma Franchise Company in Andhra Pradesh | Explore Tumblr posts and blogs

crystomed · 2 years ago

Text

Pharma Franchise In Andhra Pradesh

Starting a Pharma Franchise in Andhra Pradesh is best for you because, Andhra Pradesh is perhaps the biggest state in India with a populace of more than 49 million. The state has a flourishing drug industry with many organizations working in the state. The public authority of Andhra Pradesh has likewise been steady of the business and has established a climate that is helpful for the development of the drug area. This has prompted an expansion popular for pharma establishments in Andhra Pradesh.

Pharma establishment organizations work on a one of a kind plan of action where they collaborate with different organizations or people to market and sell their items in a specific locale. This enjoys many benefits as it permits the organization to grow its span without causing the significant expenses related with setting up another business in another locale.

Whenever you have dealt with these nuts and bolts, you can begin fabricating your pharma establishment business in Andhra Pradesh. The following are a couple of tips to assist you with getting everything rolling:

Fabricate Areas of Strength: Building areas of strength for an is urgent in the pharma establishment business. You ought to attempt to lay out associations with specialists, drug specialists, and other medical care experts in your locale. This will assist you with building believability and confidence on the lookout, and will make it simpler for you to market and sell your items.

Put resources into showcasing: Promoting is vital to the outcome of any pharma establishment business. You ought to put resources into showcasing methodologies that are custom fitted to the neighborhood market. This could remember promoting for neighborhood papers and magazines, supporting nearby occasions, or facilitating instructive workshops for medical care experts.

Offer extraordinary client support: Giving remarkable client support is fundamental in the pharma establishment business. You ought to do an amazing job to guarantee that your clients are happy with your items and administrations. This will assist you with building a faithful client base and will separate you from your rivals.

Keep awake to date with industry drifts: The drug business is continually advancing, and keeping awake to date with the most recent patterns and developments is significant. You ought to go to industry meetings and classes, read industry distributions, and organization with different experts in the business to remain informed.

Our Medicine range: Analgesic Range, Antacid, Antibiotic Range, Anticold Range, Cosmetic, Eye Range, General Range, Gynae Nutrition, Injectable Range, Nasal Spray, Nutraceutical Range, Ortho Range, Pediatric Range

Benefits of Pharma Franchise In Andhra Pradesh

Low Start-up Costs

One of the major advantages of a pharma franchise business is the low start-up costs. As a franchisee, you do not need to invest in research and development, manufacturing, or marketing. The franchisor takes care of these aspects of the business, allowing you to focus on sales and marketing activities. This significantly reduces the initial investment required to start the business.

Established Brand and Reputation

Another benefit of a pharma franchise business is that you benefit from the established brand and reputation of the franchisor. Customers are more likely to trust and buy from a well-known brand than from a new, unknown company. This can help you generate sales more quickly and establish a strong reputation in the market.

Access to High-Quality Products

As a franchisee, you have access to high-quality, tested, and approved products from the franchisor. This saves you the time and effort of developing new products, and ensures that you can offer your customers high-quality and effective products.

Training and Support

Franchisees receive training and ongoing support from the franchisor. This includes training on the products, sales techniques, and marketing strategies. The franchisor also provides ongoing support in terms of product updates, promotional materials, and customer service. This can help you operate the business more efficiently and effectively.

Reduced Risk

Starting a new business involves a lot of risks, including market risk, financial risk, and operational risk. With a pharma franchise business, you can reduce these risks significantly. The franchisor has already established the business model and has tested it successfully in the market. This reduces the risk of failure and increases the chances of success.

Flexibility

A pharma Franchise business is significantly Flexible. As you grow your client base and expand to concrete areas to monitor, You can grow your business by adding new items or organizations, enlisting additional sales representatives, or opening up new territories. It grants you to promote the business at the pace that suits you.

Pharma Franchise Business Locations in Andhra Pradesh. These are the best locations for starting your Pharmaceutical Business

Visakhapatnam

Vijayawada

Tirupati

Kakinada

Rajahmundry

Nellore

Eluru

Ongole

Anantapur

Vizianagaram

Tenali

Proddatur

Adoni

Nandyal

Think about every business, what are the benefits of a pharmaceutical franchise business, how to start it, brand promotion,Including first business things, planning and support, low probability, flexibility and adaptability. In conclusion, a pharmaceutical business offers many benefits, including low start-up costs, established brand and reputation, access to high-quality products, training and support, reduced risk, flexibility, and scalability. These advantages make a business a profitable opportunity for entrepreneurs who want to start a business in the pharmaceutical industry.

#Pharma Franchise in Andhra Pradesh #pharma franchise company #pharma franchise #pharma franchise products #pharmaceutical

0 notes

pharmafranchise22 · 2 years ago

Text

Find the Top PCD Pharma Franchise in Chandigarh, Andhra Pradesh & Maharashtra

Are you looking for the top PCD Pharma Franchise in India? Pharma Franchise is one of the top Pharma PCD Companies in Chandigarh that provides high-quality health products to our customers at the most competitive prices. Call us at +91 9877632922.

#Pharma Franchise #pharma franchise chandigarh #PCD Pharma Franchise #Pharma PCD Companies in Chandigarh #General Range PCD Companies #pharma pcd franchise in andhra pradesh #pcd pharma companies in maharashtra

1 note · View note

acinomhealthcare · 4 years ago

Text

092163 25808 How to choose best pharma company for PCD Franchise in different states

Company Overview

Acinom Healthcare and Pharmaceutical Company has been operating for more than 10 years in India as a pharmaceutical company.

The organization was set up to deliver prescription drugs of high quality at reasonable rates that increase the quality of life and provide excellent value to all of our company members.

Acinom Healthcare and Pharmaceutical Company was powered by a will to succeed and has been involved in the industry in a significantly short period, with the firm emphasis on efficiency, dedication, and execution, and effective in creating a large footprint in an increasingly competitive business setting. Our ethical strategy and straightforward market process have enabled us to build a broad domestic client base. We plan to extend our business in India and work in many countries already.

Top PCD Pharma Companies in Andhra Pradesh

We deliver PCD pharma company in Andhra Pradesh with the help of our technical facilities. We are supporting our experienced practitioners with deep expertise and experience in their area to deliver these services. The versatility, efficiency, and timely delivery of our services are established. For the potential procedures of the company, the related details are specifically taken into account. Furthermore, to fulfill our customers' particular desires, we deliver these facilities efficiently and quickly.

PCD Pharma Franchise in Assam

Acinom Healthcare and Pharmaceutical Company are now in Assam offering its PCD Pharma Franchise in Assam. Our PCD and franchise are the nation's largest pharmaceutical franchise corporation in India. For a profitable company, we have what you need. We have excellent credit quality goods at an affordable price across a broad variety.

In all major districts of Asam, such as Guwahati, Jorhat, Tezpur, Silchar, Dibrugarh, Nagaon, Haflong, Tinsukia, Sivasagar, etc, we offer PCD pharma franchises so that we invite people dealing with pharmaceuticals to our franchising partner in PCD Pharma to operate a company that is safe in the future and will grow well.

Top PCD Pharma Franchise companies in Bihar

One of the easiest things to do for a respectable organization is a lot! You are entitled exclusively to Acinom Healthcare and pharmaceutical companies in all the Bihar areas. You are a monopoly corporation in your way. Under our pharmacy franchise, we served all big districts and their municipalities. Acinom Healthcare and pharmaceutical company is the best if you want to open the PCD pharma franchise company in Bihar. We have cities covered such as:

Arrah

Begusarai

Bhagalpur

Bhojpur

Biharsharif

Chhapra

Darbhanga

Gaya

Hajipur

Katihar

Munger

Muzaffarpur

Patna

Purnea

Saharsa

At the moment; we're in Bihar with a strong vacancy. Now you can contact us to find out about our franchise business in your vicinity.

Top PCD Pharma company in Chandigarh

All processes of transformation of the raw materials to finished goods include pharmaceutical production (drugs). It complies with high national and international quality standards (Good Manufacturing Practices) which ensure that patients are held to a high-quality standard in terms of hygiene, environment, and protection.

Any pharmaceutical industry attempts to sell increasingly effective drugs of superior quality, at fair prices with the arrival of products on the market.

Despite the global financial crisis, the pharmaceutical industry is thriving. This is because of the rising need for treatment after the population is growing and new markets have been created. But the global downturn has a price effect

To appease developed nations, the production of generic drugs was unavoidable. These countries account for 20% of world demand in terms of their needs.

Briefly, the first steps are the analysis and commitment of the processes. PCD Pharma Franchise Business in Chandigarh continues with mass manufacturing after the recipe is in hand:

·The procurement of raw materials

·Wave and form

·The capsules cover and the tablet compression

·Packaging primary and secondary

·Palletization

·Stocking

After the medicines are done, the Quality Controls are also very strict.

Top PCD pharma franchise in Chhattisgarh

The pharmaceutical industry's center is Chhattisgarh. Via its perfect drug line, it has captured the hearts of many consumers. From the beginning, we started to develop our work on our weekly pieces. We plan to extend our business borders more effectively by offering our PCD Pharma Franchise in Chhattisgarh. In all the top arias of Chhattisgarh, we deliver the franchise

Raipur, Dantewada, Dhamtari, Janjgir-Champa, Mahasamund, Bilaspur, Bastar, Jashpur, Koriya, Dhamtar. We have made it very clear that our franchise goods can simple for everyone to grasp.

https://acinomhealthcare.wordpress.com/2021/02/20/how-to-select-pcd-pharma-company-in-different-states-according-to-specification/

#PCD pharma franchise in Chhattisgarh #PCD Pharma company in Chandigarh #PCD Pharma Franchise companies in Bihar #PCD Pharma Companies in Andhra Pradesh #PCD Pharma Franchise in Assam

2 notes · View notes

matinspharma · 5 years ago

Text

Matins Pharma PCD Company is among the best Derma Franchise Companies in India

Derma Product Range in PCD Franchise

Derma Range Products – Derma Products also known as Dermatology Products deals with skincare products. Derma range is the branch of medicine which deals with issues and diseases associated with Skin, Nails and Hair. These products are high quality, result-oriented safe solutions for skin diseases like acne, fungal infection, eczema, sunburn, hair loss and many more. Derma range comprises of both dermatological and cosmeceutical products.

Derma Range generally has the following product types:

Creams

Ointments

Soaps

Gels

Lotions

Serums

Dusting Powders

Tablets

Capsules

Face Wash etc.

Derma Range preparations need to be done under strict quality control as per described quality standards.

Derma PCD Franchise means PCD franchise of dermatology and cosmetic products. Derma range of products is the most sought after by franchisers across India. The basic reason is the rapidly growing demand for Derma products due to ever-increasing patients with dermatology ailments. Parties across India are looking for high quality, result-oriented fairly priced products in Derma PCD Franchise. Your search for the best Derma PCD Company ends here with MATINS PHARMA DERMA PCD FRANCHISE.

We are going to offer quality assured, fairly priced Derma range products in PCD Pharma Franchise on Monopoly basis. We are looking for PCD Franchise Partners on Pan India Basis. We are looking for Derma PCD Franchise in Maharashtra, Tamil Nadu, Andhra Pradesh, West Bengal, Assam, Rajasthan, Delhi, Mumbai, Bangalore, etc. to start with.

Benefits of association with MATINS PHARMA DERMA PCD Range –

Quality Assurance

Product availability at all times

Fairly Priced Products

High-Profit Margins

Exclusive Selling rights in your area with 100% monopoly

Promotional Support

Wide Product Range

Best in Class Packaging

State-of-the-art Manufacturing Collaboration

Rich experience in PCD Franchise

ISO 9001:2015 Certified PCD Pharma Franchise Company

Reliable Service with Same Day dispatch

The Derma Range in PCD Franchise by MATINS PHARMA, the best Derma Franchise Company in India, offers both general dermatology and cosmetology products in the PCD Franchise Model of business.

With exclusive and unique products Matins Pharma offers a wide basket of products in Derma PCD Franchise. We at Matins Pharma understand the needs and requirements in Derma PCD and our products are made as per the international standards. Skin is one of the most sensitive part of Human Body and precautions need to be taken while manufacturing Derma Range Products. It is because of all these reasons that MATINS Pharma is among the best Derma PCD Companies in India.

MATINS PHARMA is dedicated to provide the best to its PCD Franchise associates and always striving to create maximum benefits for its Franchise Partners.

For Best quality Derma PCD Franchise Contact:

MATINS PHARMA

7814644275, 8284010553

SCO : 3, Sector – 11

Panchkula – Haryana, Near Chandigarh

http://matinspharma.com/derma-pcd-franchise/

#dermapcd #dermapcdfranchise

2 notes · View notes

franchisepharma · 2 years ago

Text

Find General Range PCD Companies in Chandigarh, Maharashtra & Andhra Pradesh

Pharma Franchise is one of general range PCD Pharma Companies in Chandigarh, Maharashtra & Andhra Pradesh that provides a wide variety of pharma products of premium quality at reasonable price. Contact us +91-9958039666.

1 note · View note

dazzlehealth · 2 years ago

Text

PCD Pharma Franchise Company in Andhra Pradesh

Dazzle Healthcare is the best PCD Pharma Franchise Company in Andhra Pradesh that offers various services to their customers, such as pharmaceutical franchises and distribution of medical products. The company has over 100 franchise stores across India and provides medical facilities such as general medicine, Ayurvedic medicines, homeopathic medicines, and many more. We offer franchise opportunities to aspiring entrepreneurs. It's a company that helps people succeed by providing them with the necessary tools and training to start their own businesses. They are at the forefront of innovation and have a strong focus on customer satisfaction. The company has been operating for over 10 years. Dazzle Healthcare is a leading PCD pharma company in Andhra Pradesh with a focus on research, development, and manufacturing of pharmaceutical products.

#PCD Pharma Franchise Company

0 notes

india-today-yahoopartner-blog · 8 years ago

Text

Stocks to watch out for in 2017

India stock market failed to surpass 2015 high of 9119 and drifted towards 6825 mark just before the Union Budget 2016. Going forward as market failed to deliver major gains in the last year, so potential of performance is rising in equity market amid big-bang reform by the government. We look at stocks to watch out for in 2017.

JB Chemicals

The company plans to launch new products and improve coverage of the existing products by penetrating into Tier-II cities and the rural markets. It expects to improve productivity index without any expansion in the field force (current 1000 MRs). Further, increased registrations in the contrast media segment are likely to rev up growth in the ensuing quarters. We expect sustained growth in India led by focused portfolio (chronic) over FY2017-18E;

{blurb}

The new capex plan of about Rs 140 crore is being incurred for the creation of additional capacity for the formulations business including tablets, liquid, ointments, vials, eye drops and lozeges and for the creation of additional capacity for the API business is progressing well.

As per the latest results and also based on its FY2016, we estimate its net cash level (net of debt) at over Rs 315 crore. Net of cash, JB Chem trades at EV (Enterprise Value) to annualized sales of 2.2x, which is quite attractive as compared to many small pharma companies which trade more than 3 times its annualized sales.

The company accords high priority to domestic formulations business almost 37% of the total revenue is derived from the domestic formulation business. During the current year, the company also plans to continue to pursue focus on harnessing potential of the existing products, launch new line extensions and achieve increased productivity. The stock currently trades at attractive valuation of 12.6x its FY2018E EPS of Rs.27. Its business would be relatively least impacted by the demonetization. Hence, we continue to recommend a buy on the stock with a target price of Rs 440.

Polaris Consulting The stock price of Polaris has got corrected by 8 percent in the last 1 month and is down by 30% from its 52 week high of Rs 217. The promoters made an offer-for-sale (OFS) of 18.9 lakh equity shares at a floor price of Rs.130 per share and still have a greenshoe option of another 18.9 lakh shares.

It is quite surprising to us to see Virtusa (new promoter) making an Offer to sell shares at Rs.130 per share when they had earlier acquired the shares at an average price of Rs.213.88 per share in an open offer. In the last 3 years, the stock price of Polaris became highly volatile - however, we have observed that those investors, who utilized the opportunity to accumulate the stock after substantial fall in its price, could make impressive returns. Considering the attractive valuation, we believe that the price correction gives an opportunity to accumulate the stock in phases.

We believe that OFS does not change the fundamentals of the company. The current OFS was made to meet the minimum public shareholding norm. According to SEBI norm, all listed companies should have minimum public shareholding of 25%. As of September 30, 2016, the promoters held 78.61% stake in the company.

The stock trades at 0.6x its EV to H1FY2016 Annualized Sales which is quite impressive as compared to many mid and small cap IT stocks. The stock at the current market price trades at 8.8x its FY2017E EPS of Rs.17 and at 7.2x its FY2018E EPS of Rs.21. We reiterate our BUY on the stock at the current market price with a target price of Rs 186.

{blurb}

Bharti Infratel Tower is emerging a precious resource in this country and this business model is akin to rental revenue stream of real estate - these tower rentals will keep on rising over the years in future. Hence, this stock would remain as one of the safest defensive stocks in the long-term;

The stock price of Bharti Infratel has got corrected by 9% in the last one month. We believe that this correction is an opportunity to accumulate the stock at the current market price as we believe that Bharti Infratel will relatively remain least affected by demonetization as most of its clients are institutions where transactions through cash are almost NIL Hence revenues won't be affected by under recoveries or fall in revenues.

In our view, Bharti Infratel, with a 20 percent share of towers in India, pan-India coverage (>95% of the population) with a tenancy of 2.2x, and leading telcos as incumbent tenants for its consolidated tower portfolio, remains well entrenched to capitalize on the data-growth led network capacity requirement of telcos.

Bharti Infratel has reported an impressive performance during the September 2016 quarter: Net profit for the quarter grew by 31% y-o-y to Rs 774 crore whereas consolidated revenues for the quarter grew by 8% y-o-y. EBITDA for the quarter grew by 30% y-o-y to Rs 401.3 crore;

The Operating free cash flow during the quarter was Rs.932.1 crore, an increase of 30.4% as compared to the quarter ended Sep 30, 2015 led by higher operating income; Infratel remains a key play on rising demand of telecom towers emanating from ballooning data growth and opportunity owing to the huge quantum of spectrum and its subsequent roll out. We reiterate a BUY on the stock with a target price of Rs.405, based on 26x its FY2018E EPS of Rs.15.3.

{blurb}

KCP Sugars

The stock price of KCP Sugar and Industries has got corrected by around 33% from its peak. The fundamentals of KCP Sugar haven't changed to such an extent to warrant such a steep fall in the stock price.

As of September 30, 2016, KCP Sugar's net debt is just 7.5% of total capital employed (Net Debt: Rs 24 crore and Capital Employed: Rs 318 crore). While many sugar mills finance 3/4th of sugar inventories through borrowed capital, KCP Sugar finances 3/4th of them through own funds;

We expect the domestic sugar price to remain firm on account of lower production in Maharashtra and Karnataka on account of cane scarcity. Though prices are down from their recent peak, sugar prices are up by 26% on y-o-y basis.

KCP Sugar has around surplus land on Mount Road in Chennai which is, in our view, significantly higher (in value) than the companies' market cap of about Rs.330 crore. Apart from this, the company owns several residential properties in Chennai, Hyderabad and Industrial site with buildings in Industrial Estate TADA, Andhra Pradesh. The company has also invested in the equities of other leading sugar mills and corporate.

At the current market price the stock trades at 7.3x its FY2018E EPS of Rs 4.20.

We believe that the stock can easily reach our target price of Rs 45/ and in the long run this stock is a potential multi bagger, if it could unlock value from its surplus land bank.

Axis Bank

Axis Bank's Q2 FY2017 performance was quite below our expectations as dismal asset quality (multi-fold rise in slippages) took the sheen off an otherwise operationally stable Q2FY2017. However, we suggest a BUY on the stock as:

a. The stock price has fallen 26% from its 52-week high which, in our view, largely priced in recent spike in non-performing assets; b. The bank has become cheapest stock among its peers after the recent correction; c. We believe that, within a couple of quarters, it is likely to stabilize the NPAs; d. Bank continues to grow its credit base about two-times the industry credit growth - hence, we believe that the current price is fairly a rock bottom for the stock;

Advances continued to grow above industry average-up 18.5% yoy (albeit, lower than run rate of 22% over past 6 quarters). The spurt was largely due to healthy momentum in retail. The retail piece (including retail agriculture segment) continued to clock good performance (up 25% yoy) across segments, with higher growth in auto loans (up 41% yoy) and high-return businesses like personal loans and credit cards (up 50% yoy).

Focused branch network strategy has helped Axis garner steady accretion in the retail segment.

Management highlighted that the bank will continue to focus on higher-return businesses and expects these segments to remain on growth path. Corporate and SME loans also clocked healthy growth of 14.1% yoy and 14.4% y-o-y, respectively.

Management expects loan growth to be in the 18-20% range, driven by the retail segment. The bank at the current market price trades at 1.8x its FY2018E adjustable book value of Rs 254.

We continue to reiterate our BUY recommendation on the stock at the current market price with a revised target price of Rs 625 looking at the banks attractive valuation and its strong core business and rapidly growing franchise business. Lupin

Lupin has received 7 ANDA approvals in last two months and 23 ANDA approvals from USFDA till date in FY2017 (including tentative approvals). The approval pace has picked up after receiving EIR (Establishment Inspection Report) for its Goa plant from USFDA. The approval pace would continue in coming quarters as well, considering strong pipeline of 142 ANDAs pending approval (as per Q2FY2017 results press release) including 45 FTFs.

US: Getting ready to take-off

With $915 million revenues in FY2016, Lupin is the fifth largest generic company in the US by prescription. It has grown at 16-17% CAGR over the past five years and is likely to grow over 20% CAGR over the next two years. With 142 filings, the company has one of the largest ANDA pipelines among Indian peers. Pending filings and additional 250 projects under development represents a market size of $ 70 billion for the company;

India: Robust and Growing…

From being the largest supplier of anti-TB products in India to becoming one of the fastest growing companies in chronic therapies (like CVS, anti-diabetic, respiratory and CNS), Lupin has come a long way. Currently, it ranks 8th in the Indian pharma market, according to the July AIOCD data. Lupin continues to rank first in TB products (53% market share) and third in CVS and respiratory therapies.

We believe the long-term growth outlook for Lupin remains strong and we expect the company to regain premium multiples (vs. peers) with pick up in US approvals. We value Lupin at 22.6x its FY2018E EPS of Rs 85.4 and reiterate our BUY on the stock at a current price of Rs 1,483 with a target price of Rs 1930.

Tata Sponge Globally precious and base metal prices have rallied anywhere between 85% to 7% YTD with Iron Ore gaining the most amid a broad rally in commodities on expectations of a pick-up in global manufacturing and infrastructure spending. Following the global trend domestic prices have also rallied - with sponge iron prices gaining 36% from its May 2016 lows and gaining 9% in last 2 weeks. We believe that this rise in the domestic sponge iron prices will improve Tata Sponge Iron's performance in the coming quarters.

The stock has got corrected by around 18% from its 52W High of Rs.685 and trades at attractive valuations of 13.4x its FY2017E EPS of Rs.42 and at 9.4x its FY2018E EPS of Rs.60. Its Net Cash as of September quarter stands at Rs.522 crore which is ~60% of the current market cap.

For Q2FY2017, the company reported an over two-fold jump in its consolidated net profit at Rs.16.06 crore for the quarter ended September 30. The company had clocked a net profit of Rs 5.70 crore in the year-ago period. The company reported an operating profit of Rs.13.67 crore as compared to a loss of Rs1.99 crore reported in the same quarter last year whereas qoq it grew over 2 fold from Rs.5.10 crore reported in the previous quarter. Total consolidated income of the company, however, fell by 8% to Rs.153.55 crore in the July-September quarter from Rs.167.51 crore during the same quarter in 2015-16;

The company has also zero debt status and high cash balances, which makes its balance sheet stronger. At CMP of Rs.563 the stock is trading at 9.4x its FY2018E EPS of Rs 60/. We firmly believe that the prospects of sponge iron industry would improve substantially and hence, we reiterate our 'BUY' on the stock with a revised target price of Rs 730/-.

Bombay Burmah Trading Company The stock price of BBTC has got corrected by around 10% in last 3 months and is down by around 24% from its 52W High of Rs.673 and trades around Rs.510 which is quite attractive. Consequent to this correction the valuation discount to its investment in Britannia has expanded to 79% vs. a 70% discount earlier. While the Enterprise Value of BBTC stands at Rs 3,684 crore, the market value of its investments in Britannia is at whopping level of Rs.17,520 crore (i.e. 50.75% of Britannia's market cap of Rs 34,524 crore). This results in BBTC's Enterprise Value being at about 79% discount to its investment value in Britannia! Many holding companies enjoy discount to enterprise value as low as 45% to 50%. We firmly believe that BBTC deserves much lower discount to its investment value.

The predominant portion (almost 95%) of BBTC's total investment value comes from a single company i.e. Britannia. For many other holding companies, generally they come from several group companies - theoretically speaking, unlocking possibility from a single investment is more than what one would think of from several group companies; While many holding companies are shell companies on standalone basis, BBTC has diverse businesses on its own like plantations and automobile components. Further, being a 150-year old company it holds a lot of surplus land bank;

Moreover, BBTC, on consolidated earnings, trade at 9.3x FY2016 EPS of Rs 55/. Hence, we suggest our short term and long terms investors to accumulate the stock with a target price of Rs 650/- for short term, while our long term target price of Rs 1,130 remains intact. This target price is highly conservative in our view as at this target price also, BBTC offers a discount of 79% to its investment value of Britannia holding. G.Chokkalingam and Equinomics hold shares of JB Chemicals. They do not personally hold any other shares mentioned above directly or indirectly through friends, relatives or any proxies. However, their clients hold most of the stocks suggested above.

1. Voltas : Consumption theme and rising standard of living will support the business activities. It has made base near to Rs 300 and might head toward Rs 400 mark and recent decline is supporting to the attractive risk - reward ratio.

2. YES Bank: Strongest Bank in last 3-4 years which have given four times result. It will continue to outperform after the recent profit booking decline. It has support near to Rs 1100 zones while having the potential to head towards Rs 1350- Rs 1400 zones.

3. TVS Motor and Maruti Suzuki: These two are the outperformed stocks and may continue to do the same. Maruti is all set for Rs 5800 zones with multiple support near to Rs 4800 mark.

4. Arvind Ltd: It has come to an attractive levels so might attract buying interest as its now turning in to e-commerce space. Support near to Rs 320 and it may head towards Rs 390 and Rs 420 zones.

5. Zee Entertainment Enterprises Ltd: Media stock ZEEL has been moving upwards and strong market presence would keep it as a preferred stock. Support near to Rs 430 while on upside may retest to Rs 530 and higher levels. Recommended by Chandan Taparia, Derivatives and Technical Analyst. Taparia does not hold any stake in the above stocks he is suggesting them to his clients.

#_lmsid:a0Vd0000002uQfeEAE #_revsp:india_today_57 #markets #_category:yct:001000216 #_uuid:9be30258-93cd-342b-a6fe-6fa1ed4f1524

2 notes · View notes

hellosolace32-blog · 5 years ago

Text

PCD PHARMA FRANCHISE IN ANDHRA PRADESH

From the last 19 years Solace Biotech Limited is a leading pharmaceutical company in India. We offer best Pharma franchise Business opportunity and third party manufacturing services with attractive offers, discounts, promotional inputs and many more. At present, we are dealing PCD Pharma franchise in Andhra Pradesh and covering all states of India. At solace biotech, quality is not a word or a symbol. Quality is the way of life and thus we maintain. The commitment to provide quality and total quality and ear place of pride in the pharma industry. Also we provide attractive and qualitative packaging. We use ITC sapphire duplex paper for our pack shots. We have divided our huge product range into 10 divisions out of which two are General and rest eight are specialized divisions. We are associated with more than 500 franchises covering almost all districts of each state region wise. We are providing franchise business opportunity in South region such as Tamil Nadu, Kerala, Telangana etc. In the coming months we are launching our new division i.e.Ucified that is aur holistic and premium range of products. Apart from holistic range , we are also going to launch our male grooming products that are named Black Craft. Which will provide more opportunities to franchise associates. You need to take time to select the best company for your business. Good research can help you in dealing with the suitable company. Solace Biotech Limited is one of the top PCD Pharma Franchise Company considered best for the PCD business.

#pcdpharmafranchise #phrama business opportunity #best pharma company #pcd pharma

0 notes

pharma-franchsie-blog · 7 years ago

Text

Best Ways to Attract PCD Pharma Franchise Distributors

At present, all the top PCD pharma franchise companies in India are looking for the best ways to get more and more distributors to boost their business profitability. Convincing business partners (distributors) to choose you over other innumerable options, where all pharma companies in Chandigarh are committed to delivering exceptional services, can be a daunting task. Therefore, you should be much focused towards your business promotion and take necessary steps for it.

Here, we will discuss some of the best and new techniques to attract PCD pharma franchise distributors easily. Following are some of the measures which will enable you to take your PCD pharma franchise business to the next level:

Pharma Franchise in Himachal Pradesh

Pharma Franchise in Rajasthan

Pharma Franchise in Punjab

Support to Medical Representative:

Top PCD Pharma franchise companies in India gives rights to distributors to expand their business in allocated areas. These distributors appoint Medical representatives to contact to doctors. MRs need many promotional aids to get these products recommended. PCD Pharma franchise companies provide promotional aids like Visual Aid, Product Glossary, LBLs, Sample Catch covers, Reminder-cum-Thank You cards, MR bag, Visiting cards, Order books, Prescription Pads, Diwali and New Year Gifts to Medical Representatives. It helps the business to grow.

Pharma Franchise in Uttar Pradesh

Pharma Franchise in Madhya Pradesh

Pharma Franchise in Delhi

Social media:

Nowadays, social media has become a powerful tool for promoting businesses and brands since millions of businesses are connected with them. There are various platforms like Facebook, Twitter, LinkedIn, Pinterest, Instagram, Slideshare and more, from where you can easily reach your target audience. These platforms also have the facility for sponsored post where you can pay for advertising.

Pharma Franchise in Chhattisgarh

Pharma Franchise in Arunachal Pradesh

Pharma Franchise in Chandigarh

Blogging:

Blogging is a great way of marketing for pharma franchise companies in Chandigarh. Compose blogs and make use of web based social networking to advance them. This helps in generating a trustworthy response among customers or PCD pharma franchise distributors. Blogging provides information to the customers for which they are looking for. So, if you meet their requirements, they will trust you and your company.

Pharma Franchise in Andhra Pradesh

Pharma Franchise in Karnataka

Pharma Franchise in Jharkhand

All these tips are highly beneficial in attracting PCD pharma franchise distributors. Follow these tips with proper planning to attain your desired goal.

#pharma franchise comapnies #pharmaceutical products #pharma franchise chandigarh

0 notes

ipharmafranchiseblog-blog · 7 years ago

Text

Best Ways to Attract PCD Pharma Franchise Distributors

Pharma Franchise in Himachal Pradesh

Pharma Franchise in Rajasthan

Pharma Franchise in Punjab

Support to Medical Representative:

Pharma Franchise in Uttar Pradesh

Pharma Franchise in Madhya Pradesh

Pharma Franchise in Delhi

Social media:

Pharma Franchise in Chhattisgarh

Pharma Franchise in Arunachal Pradesh

Pharma Franchise in Chandigarh

Blogging:

Pharma Franchise in Andhra Pradesh

Pharma Franchise in Karnataka

Pharma Franchise in Jharkhand

All these tips are highly beneficial in attracting PCD pharma franchise distributors. Follow these tips with proper planning to attain your desired goal.

#pharma franchise #top pharma franchise companies #pcd pharma companies in india #top pharma franchise in chandigarh

0 notes

india-today-yahoopartner-blog · 8 years ago

Text

Stocks to watch out for in 2017

JB Chemicals

{blurb}

KCP Sugars

At the current market price the stock trades at 7.3x its FY2018E EPS of Rs 4.20.

We believe that the stock can easily reach our target price of Rs 45/ and in the long run this stock is a potential multi bagger, if it could unlock value from its surplus land bank.

Axis Bank

Focused branch network strategy has helped Axis garner steady accretion in the retail segment.

Management expects loan growth to be in the 18-20% range, driven by the retail segment. The bank at the current market price trades at 1.8x its FY2018E adjustable book value of Rs 254.

US: Getting ready to take-off

India: Robust and Growing…

3. TVS Motor and Maruti Suzuki: These two are the outperformed stocks and may continue to do the same. Maruti is all set for Rs 5800 zones with multiple support near to Rs 4800 mark.

4. Arvind Ltd: It has come to an attractive levels so might attract buying interest as its now turning in to e-commerce space. Support near to Rs 320 and it may head towards Rs 390 and Rs 420 zones.

#_lmsid:a0Vd0000002uQfeEAE #_revsp:india_today_57 #markets #_uuid:5c3f31f3-bc82-37b4-b671-d21fc49c4813 #_category:yct:001000216

1 note · View note

india-today-yahoopartner-blog · 8 years ago

Text

Stocks to watch out for in 2017

JB Chemicals

{blurb}

KCP Sugars

At the current market price the stock trades at 7.3x its FY2018E EPS of Rs 4.20.

We believe that the stock can easily reach our target price of Rs 45/ and in the long run this stock is a potential multi bagger, if it could unlock value from its surplus land bank.

Axis Bank

Focused branch network strategy has helped Axis garner steady accretion in the retail segment.

Management expects loan growth to be in the 18-20% range, driven by the retail segment. The bank at the current market price trades at 1.8x its FY2018E adjustable book value of Rs 254.

US: Getting ready to take-off

India: Robust and Growing…

3. TVS Motor and Maruti Suzuki: These two are the outperformed stocks and may continue to do the same. Maruti is all set for Rs 5800 zones with multiple support near to Rs 4800 mark.

4. Arvind Ltd: It has come to an attractive levels so might attract buying interest as its now turning in to e-commerce space. Support near to Rs 320 and it may head towards Rs 390 and Rs 420 zones.

#_uuid:4b969aec-b862-38b6-ae5c-f3cb1ad6e1d3 #_lmsid:a0Vd0000002uQfeEAE #_revsp:india_today_57 #markets #_category:yct:001000216

1 note · View note